Stock detail

Selçuk Ecza Deposu Ticaret ve Sanayi A.Ş.

SELECSTOCKS | TR | IST | Healthcare | Medical Distribution

Profile snapshotTRY 73.6Market cap TRY 45.7B

No local candle data found.

Recent detected patterns / setups

Latest 10 Market Radar results for this symbol and selected direction.

PatternTFScan runQuality

BullishICT BOS Retest Setup4H07 Nov 26, 16:1672

BullishSupport/Resistance Flip Setup4H07 Nov 26, 16:1675

BearishICT Inverse FVG Setup4H07 Nov 26, 16:1676

BullishMA 8/21 Crossover4H07 Nov 26, 16:1681

BullishSupport/Resistance Flip Setup15M07 Nov 26, 09:1476

BullishOliver Kell Momentum Setup15M07 Nov 26, 09:1481

BearishICT Inverse FVG Setup15M07 Nov 26, 09:1488

BearishSupport/Resistance Flip Setup1D06 Nov 26, 15:2370

BearishICT Inverse FVG Setup1D06 Nov 26, 15:2399

About Selçuk Ecza Deposu Ticaret ve Sanayi A.Ş.

Selçuk Ecza Deposu Ticaret ve Sanayi A.Ş. (SELEC) is listed on IST. Sector: Healthcare. Industry: Medical Distribution.

Selçuk Ecza Deposu Ticaret ve Sanayi A.S., together with its subsidiary, operates as a pharmacy depot in Turkey. In addition, the company is involved in operation of pharmaceutical warehouses; and distributes cosmetics, personal care, infant food, vitamins, medical, and other products. The company was founded in 1958 and is based in Istanbul, Turkey. Selçuk Ecza Deposu Ticaret ve Sanayi A.S. is a subsidiary of Selçuk Ecza Holding A.S.

Annual

Annual fundamentals

2025 vs previous annual period

Total revenueTRY 172B+2.2%

Net incomeTRY -379.8M-114.1%

Net profit margin-0.2%-1.8 pp

EPS-0.61-114.1%

Total debtTRY 795.9M-92.4%

Cash and cash equivalentsTRY 1.1B-72.6%

Net debtTRY -318M-104.9%

Metric20212022202320242025

Total revenue----TRY 85.2B--TRY 141.1B+65.6%TRY 168.4B+19.3%TRY 172B+2.2%

Net income----TRY 635.7M--TRY 322.3M-49.3%TRY 2.7B+736.2%TRY -379.8M-114.1%

Net profit margin----0.7%--0.2%-69.4%1.6%+600.7%-0.2%-113.8%

EPS----1.02--0.52-49.3%4.34+736.0%-0.61-114.1%

Free cash flow----TRY -1.4B--TRY 1.7B+221.8%TRY -12.2B-818.7%TRY 6.4B+152.1%

Total debt----TRY 478.9M--TRY 3.5B+628.3%TRY 10.5B+201.4%TRY 795.9M-92.4%

Cash and cash equivalents----TRY 1.1B--TRY 6.4B+472.3%TRY 4.1B-36.4%TRY 1.1B-72.6%

Net debt----TRY -640.4M--TRY -2.9B-355.7%TRY 6.4B+320.7%TRY -318M-104.9%

Quarterly

Quarterly fundamentals

Q2 2026 vs same quarter previous year

Total revenueTRY 53.4B+2.9%

Net incomeTRY 534.4M-65.3%

Net profit margin1.0%-2.0 pp

EPS0.86-65.3%

Total debtTRY 6.1B+1.0%

Cash and cash equivalentsTRY 4.2B-3.7%

Net debtTRY 1.9B+13.4%

MetricQ1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026

Total revenue----TRY 47.7B--TRY 42.2B--TRY 48.3B--TRY 51.9B--TRY 53.4B+12.0%

Net income----TRY -424.7M--TRY -222.6M--TRY 186M--TRY 1.5B--TRY 534.4M+225.8%

Net profit margin-----0.9%---0.5%--0.4%--3.0%--1.0%+212.3%

EPS0---0.68---0.36------2.48+61875.0%0.86+225.9%

Free cash flow----TRY 2.3B--TRY -2.4B--TRY 1B--TRY -2.1B--TRY -609.1M-127.0%

Total debt----TRY 1.9B--TRY 2B--TRY 795.9M--TRY 6.1B--TRY 6.1B+221.3%

Cash and cash equivalents----TRY 2.6B--TRY 1.8B--TRY 1.1B--TRY 4.4B--TRY 4.2B+61.1%

Net debt----TRY -712.2M--TRY 193.5M--TRY -318M--TRY 1.7B--TRY 1.9B+369.1%

Ownership

Institutional ownership summary

2026 Q4, quarter ended 2026-11-07

PeriodOwnershipInstitutions13F sharesTotal investedPositionsPut/call